Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CNA vs PRE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CNA Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)

CNA Overall Winner 6-Pillar Tally: CNA 5 – 1 PRE Matrix Metrics: CNA 9 – 1 PRE

As of Nov 16, 2026, CNA Financial Corporation (CNA) is the stronger overall head-to-head candidate over Prenetics Global Limited Class A Ordinary Share (PRE) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CNA carries a Unified Composite Score of 55.0/100 (HOLD) at $48.50 (10.5x Forward P/E, 9.4% operating margin), whereas PRE carries 49.8/100 (HOLD) at $15.48 (N/M Forward P/E, -34.6% operating margin).

  • Growth vs. Quality Trade-Off: CNA earns the overall head-to-head edge with a stronger Unified Composite Score (55.0/100 HOLD vs. PRE 49.8/100 HOLD) and -0.14β · 19% Vol risk profile, whereas PRE leads top-line expansion (+210.7% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: CNA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 55.3); meanwhile PRE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CNA vs PRE
CNA NYSE Head-to-Head Winner
CNA Financial Corporation
Fire, Marine & Casualty Insurance
$48.50
-0.1% 1D
Market Cap $13.1B
TTM Revenue $15.2B
Forward P/E 10.5x
Beta / 30D Vol -0.14β · 19% Vol
Unified Composite Score
55.0 / 100 HOLD
Tech 73.0 Fund 58.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 55
RSI-14: 55.3 · SMA20: $48.21 · SMA50: $47.46
PRE NASDAQ
Prenetics Global Limited Class A Ordinary Share
Laboratory Analytical Instruments
$15.48
-6.24% 1D
Market Cap $322.2M
TTM Revenue $155M
Forward P/E N/M
Beta / 30D Vol 1.63β · 74% Vol
Unified Composite Score
49.8 / 100 HOLD
Tech 33.0 Fund 59.0 Flow 76.0 Mom 67.8
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.0%), weak momentum, RSI 35
RSI-14: 35.1 · SMA20: $17.16 · SMA50: $20.26

6-Pillar Scorecard Institutional Category Breakdown (CNA 5 – 1 PRE)

Columns: Metric · CNA · PRE
1. Valuation Multiples CNA
Forward P/E 10.5x N/M
Trailing P/E 12.8x N/M
PEG Ratio 0.92x N/M
EV / Revenue 0.9x 1.7x
2. Growth & Scale PRE
Revenue Growth (YoY) +0.1% +210.7%
Earnings Growth (YoY) -51.4% +0.0%
TTM Revenue (USD) $15.2B $155M
Market Cap $13.1B $322.2M
3. Profitability & Quality CNA
Gross Margin 29.0% 57.8%
Operating Margin 9.4% -34.6%
Net Profit Margin 6.8% -30.4%
Return on Equity (ROE) 9.6% -47.0%
4. Balance Sheet & Cash Flow CNA
Cash Generation (TTM) $1.50B EBITDA -$54M EBITDA
Cash Flow Margin 9.9% EBITDA Mgn -34.9% EBITDA Mgn
Net Cash / Leverage $37.80 Book/Sh · 9.6% ROE $58M Net Cash
Dividend Yield 3.93% None (0.00%)
5. Options & Positioning CNA
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 13.0% (<1st %ile) 124.1% (18th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CNA
OpEx & R&D Intensity 19.6% of Rev ($2.97B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance - Property & Casualty Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CNA (9) vs PRE (1)
Institutional Metric CNA PRE Criterion Row Edge
Market Capitalization
Scale
$13.1B $322.2M Larger Scale CNA
Trailing P/E Ratio
Valuation
12.8x N/M Lower Multiple CNA
Forward P/E Ratio
Valuation
10.5x N/M Lower Multiple CNA
Revenue Growth (YoY)
Growth
+0.1% +210.7% Higher Growth PRE
Operating Margin (TTM)
Profitability
9.4% -34.6% Higher Margin CNA
Net Profit Margin
Profitability
6.8% -30.4% Higher Margin CNA
Return on Equity (ROE)
Capital Efficiency
9.6% -47.0% Higher ROE CNA
52-Week Range Position
Momentum
49% ($42–$56) 26% ($11–$27) Stronger Trend CNA
Beta / 30D Volatility
Risk Regime
-0.14β · 19% Vol 1.63β · 74% Vol Lower Realized Risk CNA
Unified Institutional Score
Composite Signal
55.0 / 100 (HOLD) 49.8 / 100 (HOLD) Higher Composite CNA
Trailing 12M Revenue (USD)
Operating Scale
$15.2B $155M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
29.0% 57.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.92x PEG · 0.9x EV/Rev N/M PEG · 1.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.50B EBITDA ($37.80 Book/Sh · 9.6% ROE) -$54M EBITDA ($58M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CNA +17.66 pp
CNA: +1.25% · PRE: -16.41%
3M Horizon CNA +16.57 pp
CNA: -3.64% · PRE: -20.21%
6M Horizon CNA +2.73 pp
CNA: +9.19% · PRE: +6.46%
1Y Horizon PRE +9.9 pp
CNA: +5.02% · PRE: +14.92%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CNA vs PRE. Trailing 12-month operating profitability (CNA 9.4% vs PRE -34.6%) and valuation multiples (CNA 10.5x vs PRE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CNA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$15.2B
Gross Margin29.0%
Op. Margin9.4%
ROE / Fwd P/E9.6% · 10.5x
PRE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$155M
Gross Margin57.8%
Op. Margin-34.6%
ROE / Fwd P/E-47.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CNA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 13.0%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CNA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PRE BREAKDOWN
56d in phase · OBV NEUTRAL
Current IV 124.1%
IV Percentile 18th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact PRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CNA Moat Profile Cyclical / Execution-Driven Positioning
Insurance - Property & Casualty Operator
Competes within the Insurance - Property & Casualty value chain with $13.1B market capitalization and 9.4% operating margin.
OpEx & R&D Reinvestment 19.6% of Rev ($2.97B)
90D Engineering Disclosures 0 Published
PRE Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $322.2M market capitalization and -34.6% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CNA vs PRE Key Questions & Quantitative Answers

As of Nov 16, 2026, CNA Financial Corporation (CNA) is the stronger overall head-to-head candidate over Prenetics Global Limited Class A Ordinary Share (PRE) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CNA carries a Unified Composite Score of 55.0/100 (HOLD) at $48.50 (10.5x Forward P/E, 9.4% operating margin), whereas PRE carries 49.8/100 (HOLD) at $15.48 (N/M Forward P/E, -34.6% operating margin). Growth vs. Quality Trade-Off: CNA earns the overall head-to-head edge with a stronger Unified Composite Score (55.0/100 HOLD vs. PRE 49.8/100 HOLD) and -0.14β · 19% Vol risk profile, whereas PRE leads top-line expansion (+210.7% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CNA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 55.3); meanwhile PRE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PRE leads the Growth & Scale pillar: CNA posts +0.1% YoY revenue growth and -51.4% YoY earnings growth on $15.2B TTM revenue (29.0% gross margin, 9.4% operating margin), compared with PRE at +210.7% YoY revenue growth and +0.0% YoY earnings growth on $155M TTM revenue (57.8% gross margin, -34.6% operating margin). On trailing 12-month operating scale, CNA generates $15.2B in USD-normalized revenue versus $155M for PRE. In operating R&D and SG&A reinvestment, CNA deploys 19.6% of Rev ($2.97B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PRE.

CNA screens cheaper on headline valuation multiples. CNA trades at 10.5x Forward P/E, 12.8x Trailing P/E, 0.92x PEG, and 0.9x EV/Revenue (9.9% EBITDA margin), whereas PRE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.7x EV/Revenue (-34.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CNA (9.6% ROE) versus PRE (-47.0% ROE) capital efficiency.

In options market volatility and institutional positioning, CNA carries 13.0% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.14β · 19% Vol realized risk). By comparison, PRE carries 124.1% implied volatility (18th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.63β · 74% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.